Indexé dans
- RechercheRef
- Université Hamdard
- EBSCO AZ
- Fondation genevoise pour la formation et la recherche médicales
- Pub européen
- Google Scholar
Liens utiles
Partager cette page
Dépliant de journal
Revues en libre accès
- Agriculture et aquaculture
- Alimentation et nutrition
- Biochimie
- Bioinformatique et biologie des systèmes
- Business & Management
- Chimie
- Génétique et biologie moléculaire
- Immunologie & Microbiologie
- Ingénierie
- La science des matériaux
- Neurosciences & Psychologie
- Science générale
- Sciences cliniques
- Sciences environnementales
- Sciences médicales
- Sciences pharmaceutiques
- Sciences vétérinaires
- Soins infirmiers et soins de santé
Abstrait
Orphan Drug Designations in Ophthalmology
William C. Stewart, Shilla Marie Hernandez, Jeanette A. Stewart RN and Lindsay A. Nelson BS
Purpose: To evaluate orphan drug designations within ophthalmology since passage of the Orphan Drug Act and their ultimate availability and utility to the ophthalmic community.
Methods: The study design was a retrospective, observational review of orphan drug designations in ophthalmology.
Results: We identified 72 new ophthalmic drugs that received an orphan drug designation, of which four received NDA approval and all became commercially available, three for ocular and one for systemic indications.
Conclusions: This study suggests a low rate of commercialization of new ocular pharmaceutical agents with an orphan designation being approved for the original indication.